Join the Gilotrif group to help and get support from people like you.
Gilotrif News
FDA Approves New Indication for Gilotrif (afatinib) in EGFR Mutation-Positive NSCLC
Ridgefield, Conn., January 16, 2018 – Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Gilotrif (...
FDA Approves Gilotrif (afatinib) for Patients with Squamous Cell Carcinoma of the Lung
Ridgefield, Conn., April 15, 2016, Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Gilotrif® ...
Ask a question
To post your own question to this support group, sign in or create an account.